Doctor led female hair loss clinic · Parsons Green68 five star patient reviewsGMC registered doctor · CQC registered clinic020 8044 2081

JournalFemale Hair Loss

Frontal Fibrosing Alopecia: Scarring Hair Loss at Menopause

Discover how menopause-related hormonal changes can cause permanent hair loss through frontal fibrosing alopecia, a scarring condition affecting women over fifty.

Medically reviewed by Dr Amy Vowler, GP, on

Updated 10 minute read

A wide-brimmed straw hat resting on an oak console table in a bright hallway

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare or medical professional before making changes to your health routine or starting any new treatments. Some images have been created with AI for illustrative purposes only.

Portable fan and eyebrow pencil on a bathroom vanity

Introduction

If you’ve noticed your hairline gradually receding during menopause, you’re not alone in wondering whether this is simply age-related hair thinning or something more concerning. For an increasing number of postmenopausal women, this progressive hairline recession may actually signal frontal fibrosing alopecia (FFA), a form of scarring hair loss that’s been described as a modern epidemic amongst women over fifty.

Could your receding hairline be scarring?Trichoscopy magnifies your scalp and follicles to show what the eye can't, which helps tell different types of hair loss apart. A Hair GP doctor reads the images with you. See how trichoscopy works

Unlike typical menopausal hair loss that can often be reversed with treatment, FFA causes permanent hair loss by destroying hair follicles and replacing them with scar tissue. This condition primarily affects the frontal hairline and eyebrows, creating a distinctive band-like pattern of hair loss that slowly advances backwards.

This comprehensive guide will help you understand the complex mechanisms behind this autoimmune condition, from how it differs from other types of hair loss to the hormonal changes during menopause that may trigger its onset. You’ll discover the diagnostic procedures specialists use to identify FFA, explore evidence-based treatment options that can halt progression, and learn practical strategies for managing both the physical and emotional aspects of living with this condition. Whether you’re seeking answers about your own receding hairline or supporting someone affected, this resource provides the clarity you need.

Key points

  • Frontal fibrosing alopecia affects 1 in 50 postmenopausal women, causing permanent scarring and hairline recession
  • Early diagnosis through scalp biopsy and prompt treatment with anti-inflammatory medications can slow progression by up to 80%
  • Hormonal changes during menopause, particularly declining oestrogen levels, trigger the autoimmune response that destroys hair follicles
  • Treatment options include oral finasteride, dutasteride, and hydroxychloroquine, which may help stabilise hair loss when started early

What is frontal fibrosing alopecia?

Frontal fibrosing alopecia represents a distinctive form of scarring alopecia that permanently destroys hair follicles along the frontal hairline and temples. First described in 1994, FFA is now recognised as a variant of lichen planopilaris, affecting predominantly postmenopausal women with increasing prevalence worldwide[1]. Unlike androgenetic alopecia, which causes follicle miniaturisation that can potentially be reversed, FFA triggers an inflammatory process that replaces healthy follicles with scar tissue, making hair loss irreversible once follicles are destroyed.

The autoimmune connection

The development of frontal fibrosing alopecia stems from an autoimmune reaction where the body’s immune system mistakenly attacks healthy hair follicles. Research demonstrates that T-lymphocytes infiltrate the follicular bulge region, targeting stem cells essential for hair regeneration[2]. This immune-mediated assault triggers a destructive inflammatory cascade involving cytokines and chemokines that progressively damage the follicular structure.

As inflammation persists, the follicle’s supporting structures collapse, and fibroblasts deposit collagen where hair follicles once existed. This scarring process distinguishes FFA from temporary hair loss conditions—whilst telogen effluvium or stress-related shedding preserve follicle integrity, the autoimmune disease mechanism in FFA permanently eliminates the follicle’s regenerative capacity. The resulting smooth, shiny skin lacks visible follicular openings, a hallmark feature that helps clinicians differentiate this scarring alopecia from other forms of hair loss affecting the hairline.

How hair follicles are destroyed in FFA

In frontal fibrosing alopecia, the immune system mistakenly identifies hair follicles along the frontal hairline as foreign invaders, triggering a relentless inflammatory assault that leads to permanent hair loss. This autoimmune response begins when lymphocytes and other inflammatory cells infiltrate the upper portion of hair follicles, particularly targeting the bulge region where stem cells reside[3].

As these immune system cells accumulate, they release inflammatory mediators that progressively damage the follicular structure. The sustained inflammation triggers a cascade of molecular events that ultimately leads to the destruction of the hair follicle’s epithelial components. This inflammatory process activates fibroblasts, which begin excessive collagen production in an attempt to repair the damaged tissue[4].

However, instead of restoring normal tissue architecture, this repair mechanism results in fibrosis – the replacement of functional hair follicles with dense scar tissue. Once this scarring process is complete, the hair follicles are permanently destroyed and cannot regenerate, as the stem cell reservoir essential for hair cycling has been eliminated. The end result is smooth, shiny skin where hair once grew, a hallmark of this irreversible form of alopecia.

Common hair loss conditions vs. frontal fibrosing alopecia

Understanding the differences between frontal fibrosing alopecia and other hair disorders proves essential for accurate diagnosis and appropriate treatment selection. Whilst several conditions cause hairline recession and thinning, each presents unique characteristics that distinguish FFA from common types like female pattern hair loss, alopecia areata, and telogen effluvium.

Female pattern hair loss differences

Female pattern hair loss, also known as androgenetic alopecia, differs markedly from FFA in both presentation and progression. Whilst androgenetic alopecia causes diffuse thinning across the crown and preserves the frontal hairline, FFA creates a distinct band-like recession with scarring. Female pattern hair loss typically progresses gradually over years without inflammation, whereas FFA advances with visible redness and permanent follicle destruction.

The reversibility comparison reveals crucial distinctions amongst various hair disorders. Alopecia areata creates round, smooth patches that often regrow spontaneously, contrasting with FFA’s irreversible scarring pattern. Similarly, telogen effluvium causes temporary, diffuse shedding following stress or illness, with complete recovery expected within months. Even traction alopecia, caused by prolonged tension on hair follicles, may partially reverse when detected early—unlike FFA’s permanent damage.

Treatment responses further differentiate these conditions. Whilst androgenetic alopecia responds well to minoxidil and anti-androgen therapies, FFA requires anti-inflammatory medications to halt progression. This fundamental difference underscores why accurate diagnosis through our comprehensive hair loss diagnosis guide remains vital before initiating any treatment comparison or therapeutic intervention.

How is frontal fibrosing alopecia diagnosed?

Diagnosing frontal fibrosing alopecia requires careful clinical evaluation by a Dermatologist who specialises in hair disorders. The diagnosis typically combines thorough medical history, physical examination, and often a scalp biopsy to confirm the characteristic inflammatory patterns[5].

Your dermatologist will first examine your hairline recession pattern, looking for the distinctive band-like hair loss and absent follicular openings that characterise FFA. They’ll assess eyebrow involvement, check for facial papules, and use dermoscopy to identify diagnostic features like perifollicular erythema and follicular hyperkeratosis. Finding a specialist experienced in scarring alopecia ensures accurate diagnosis, as FFA can mimic other conditions requiring different treatments.

The scalp biopsy process

When clinical findings suggest FFA, a skin biopsy provides definitive diagnosis by revealing microscopic inflammatory patterns[6]. The procedure involves numbing a small area with local anaesthetic before removing a 4mm tissue sample using a circular blade. Most patients experience minimal discomfort during biopsy preparation, with the anaesthetic injection being the only noticeable sensation. Under the microscope, pathologists identify lymphocytic infiltration around follicles and replacement of hair structures with scar tissue, confirming the diagnosis.

The menopause connection: how hormones affect hair growth

The hormonal shifts during menopause create a perfect environment for frontal fibrosing alopecia development in genetically susceptible women. Declining oestrogen levels, combined with relative androgen dominance, trigger inflammatory pathways that specifically target frontal hairline follicles, accelerating the scarring process characteristic of FFA.

Oestrogen’s protective role in hair health

Oestrogen receptors within hair follicles play crucial protective roles in maintaining healthy hair growth throughout reproductive years[7]. These sex hormones extend the anagen phase, allowing hair to grow longer and thicker whilst suppressing inflammatory mediators that could damage follicular structures. During menopause, oestrogen levels decline by up to 80%, removing this protective shield and exposing follicles to inflammatory assault[8].

The hormonal changes create a relative androgen excess, even when testosterone levels remain normal. This shift activates androgen-sensitive pathways in frontal scalp follicles, triggering miniaturisation and inflammation. Post menopausal women experience accelerated follicular damage as inflammatory cytokines increase without oestrogen’s moderating influence[9].

Hormone replacement therapy can potentially slow FFA progression by restoring oestrogen’s protective effects[10]. However, timing matters significantly—early intervention during perimenopause shows better outcomes than treatment started years after menopause. Hormone testing helps identify specific imbalances, allowing tailored HRT approaches that optimise hair growth whilst minimising systemic risks. Understanding these mechanisms enables targeted therapeutic strategies for managing FFA in menopausal women.

Disease development: risk factors and triggers

Understanding frontal fibrosing alopecia disease development requires examining multiple converging factors. Research indicates a strong genetic component, with approximately 8% of patients reporting family history of the condition[11]. This genetic predisposition appears most prominent in individuals of European descent, though cases emerge across all ethnic backgrounds.

Environmental factors increasingly dominate research attention, particularly regarding cosmetic products. Studies suggest sunscreen ingredients and facial moisturisers containing chemical UV filters may trigger susceptible individuals[12]. The dramatic rise in FFA cases since the 1990s coincides with widespread adoption of daily skincare routines, supporting environmental trigger theories.

Additional risk factors include postmenopausal hormonal changes, autoimmune conditions, and certain medications. Early warning signs often include eyebrow loss preceding hairline recession by several years. Whilst genetic predisposition represents a non-preventable factor, identifying and avoiding potential environmental triggers offers some control. Current research explores whether genetic testing could identify at-risk individuals before symptom onset, though such screening remains experimental.

Treatment options for frontal fibrosing alopecia

Treatment options for frontal fibrosing alopecia focus on halting disease progression rather than complete reversal, requiring realistic expectations about outcomes. Medical treatment protocols combine anti-inflammatory agents with hormonal modulators to address both immune-mediated inflammation and hormonal triggers, with early intervention showing the most promising results[13].

Anti-inflammatory medications

Topical and oral corticosteroids remain first-line anti-inflammatory treatments for managing active FFA. High-potency topical steroids applied to affected hairline areas can reduce inflammation and potentially slow progression[14]. Intralesional steroid injections, typically triamcinolone acetonide at 2.5-5mg/ml concentrations, target localised inflammatory infiltrates around follicles. Oral hydroxychloroquine, an immunomodulator borrowed from rheumatology, demonstrates efficacy in combination therapy protocols[10].

Responses vary considerably, and combination approaches are often used. Oral finasteride, particularly at 2.5-5mg daily doses, provides effective treatment by blocking 5-alpha reductase and reducing scalp dihydrotestosterone levels[15]. Dutasteride offers broader enzyme inhibition, potentially benefiting non-responders to finasteride. Minoxidil serves as adjunctive therapy, promoting residual follicle activity whilst primary treatments address underlying inflammation.

Emerging laser therapy protocols show promise for resistant cases, though evidence remains limited. Other treatments including oral isotretinoin and mycophenolate mofetil provide alternatives when standard therapies fail. Treatment timelines typically require 6-12 months for stabilisation assessment, with maintenance therapy often necessary to prevent recurrence[16].

Living with FFA: mental health and hair restoration options

Living with frontal fibrosing alopecia significantly impacts mental health and quality of life, making emotional support and practical restoration options essential components of comprehensive care. Whilst the permanent nature of hair loss presents challenges, various cosmetic solutions and support resources help patients maintain confidence and wellbeing.

Hair transplant candidacy

Hair transplant surgery offers hope for suitable FFA patients, though careful timing and assessment prove crucial for success. Disease stability for at least 12-24 months remains the primary requirement, as transplanting into active inflammation typically results in graft failure. Results vary, and surgery is only considered when the disease has been inactive for some time.

Beyond surgical options, immediate cosmetic solutions provide essential confidence restoration. High-quality wigs and hairpieces offer versatility and instant coverage, whilst hair extensions can enhance remaining hair density. Support groups, both online and in-person, provide invaluable emotional resources where patients share experiences and coping strategies.

Mental health support should not be overlooked—many patients benefit from counselling to process grief associated with appearance changes. Camouflage techniques, including scalp micropigmentation and specialist makeup, offer additional options for concealing affected areas whilst awaiting disease stabilisation or considering other options.

Conclusion

Frontal fibrosing alopecia represents a complex condition requiring prompt recognition and expert management. Whilst the hair loss associated with this condition results in permanent follicular damage, early diagnosis significantly impacts treatment outcomes and overall prognosis. The key lies in recognising initial symptoms and seeking professional evaluation before extensive progression occurs.

Modern treatment options offer genuine hope for controlling disease activity and preserving remaining hair. A specialist hair Doctor can develop a personalised management strategy tailored to your specific presentation, considering factors such as disease severity, progression rate, and individual response patterns. These specialists possess the expertise necessary to differentiate FFA from other conditions and implement evidence-based interventions.

Living with frontal fibrosing alopecia undoubtedly affects quality of life, but proper medical care makes a substantial difference. If you’ve noticed unexplained hairline recession, eyebrow thinning, or other concerning changes, don’t delay seeking evaluation. Schedule a consultation with a Hair Loss specialist who can provide accurate diagnosis and initiate appropriate treatment. Taking action today protects your future hair health and wellbeing.

If you're not sure what kind of hair loss you have, a trichoscopy scan can show what is happening at the follicle. See how trichoscopy works

Frequently asked questions

References

  1. Griggs J, Trüeb RM, Gavazzoni Dias MFR, Hordinsky M, Tosti A. Fibrosing alopecia in a pattern distribution. J Am Acad Dermatol. 2021. PMID: 31926219
  2. Ryan GE, Harris JE, Richmond JM. Resident Memory T Cells in Autoimmune Skin Diseases. Front Immunol. 2021. PMID: 34012438
  3. Blume-Peytavi U, Hillmann K, Constantinou A, Vogt A. [Frontal fibrosing alopecia-update]. Hautarzt. 2022. PMID: 35394176
  4. Parlati L, Régnier M, Guillou H, Postic C. New targets for NAFLD. JHEP Rep. 2021. PMID: 34667947
  5. Fechine COC, Valente NYS, Romiti R. Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features. An Bras Dermatol. 2022. PMID: 35379508
  6. Miteva M, Romanelli P, Tosti A. Pigmented casts. Am J Dermatopathol. 2014. PMID: 23823025
  7. Fischer TW, Slominski A, Tobin DJ, Paus R. Melatonin and the hair follicle. J Pineal Res. 2008. PMID: 18078443
  8. Owecka B, Tomaszewska A, Dobrzeniecki K, Owecki M. The Hormonal Background of Hair Loss in Non-Scarring Alopecias. Biomedicines. 2024. PMID: 38540126
  9. Wagner G, Meyer V, Sachse MM. [Frontal fibrosing alopecia]. Hautarzt. 2016. PMID: 27538878
  10. Kępińska K, Jałowska M, Bowszyc-Dmochowska M. Frontal Fibrosing Alopecia - a review and a practical guide for clinicians. Ann Agric Environ Med. 2022. PMID: 35767748
  11. Messenger AG, Asfour L, Harries M. Frontal Fibrosing Alopecia: An Update. Am J Clin Dermatol. 2025. PMID: 39699852
  12. Abdel Azim S, Bainvoll L, Vecerek N, DeLeo VA, Adler BL. Sunscreens part 2: Regulation and safety. J Am Acad Dermatol. 2025. PMID: 38777185
  13. Singh S, Muthuvel K. Role of Hair Transplantation in Scarring Alopecia-To Do or Not to Do. Indian J Plast Surg. 2021. PMID: 34984092
  14. Valdez-Zertuche JA, Ramírez-Marín HA, Tosti A. Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review. Expert Opin Drug Metab Toxicol. 2025. PMID: 39893632
  15. Hu AC, Chapman LW, Mesinkovska NA. The efficacy and use of finasteride in women: a systematic review. Int J Dermatol. 2019. PMID: 30604525
  16. Tanha AE, Ghane Y, Jafarzadeh A, Goodarzi A. A systematic review of procedural modalities in the treatment of lichen planopilaris, frontal fibrosing alopecia, and discoid lupus erythematosus. Lasers Med Sci. 2025. PMID: 41081974
Dr Amy Vowler examining a patient's scalp
Book a consultation

Could your receding hairline be scarring?

Trichoscopy magnifies your scalp and follicles to show what the eye can't, which helps tell different types of hair loss apart. A Hair GP doctor reads the images with you.

£300 consultation · 50 minutes with a Hair GP doctor · 29 Basuto Road, Parsons Green
Next day appointments often available

  • CQC registered
  • Doctor led
  • No obligation

The journal

More from the journal.

All articles

Condition

Frontal Fibrosing Alopecia

Frontal fibrosing alopecia (FFA) is a scarring condition that causes permanent hairline recession. It can't be reversed where scarring has occurred — but treatment…

6 July 2025

Female Pattern Hair Loss vs Telogen Effluvium

Heavy shedding and gradual thinning are different conditions with different fixes. How to tell telogen effluvium from female pattern hair loss — and what…

Book consultation
WhatsAppEmailLocation
Share to...